Your browser doesn't support javascript.
loading
CD8 T cell tolerance to a tumor-associated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptor.
Ghorashian, Sara; Veliça, Pedro; Chua, Ignatius; McNicol, Anne-Marie; Carpenter, Ben; Holler, Angelika; Nicholson, Emma; Ahmadi, Maryam; Zech, Mathias; Xue, Shao-An; Uckert, Wolfgang; Morris, Emma; Chakraverty, Ronjon; Stauss, Hans J.
  • Ghorashian S; Institute of Immunity and Transplantation, University College London, Royal Free Hospital, London NW3 2PF, United Kingdom; Transplantation Immunology Group, Department of Haematology, Division of Cancer Studies, University College London, London NW3 2PF, United Kingdom; and.
  • Veliça P; Institute of Immunity and Transplantation, University College London, Royal Free Hospital, London NW3 2PF, United Kingdom; Transplantation Immunology Group, Department of Haematology, Division of Cancer Studies, University College London, London NW3 2PF, United Kingdom; and.
  • Chua I; Institute of Immunity and Transplantation, University College London, Royal Free Hospital, London NW3 2PF, United Kingdom;
  • McNicol AM; Institute of Immunity and Transplantation, University College London, Royal Free Hospital, London NW3 2PF, United Kingdom;
  • Carpenter B; Transplantation Immunology Group, Department of Haematology, Division of Cancer Studies, University College London, London NW3 2PF, United Kingdom; and.
  • Holler A; Institute of Immunity and Transplantation, University College London, Royal Free Hospital, London NW3 2PF, United Kingdom;
  • Nicholson E; Institute of Immunity and Transplantation, University College London, Royal Free Hospital, London NW3 2PF, United Kingdom;
  • Ahmadi M; Institute of Immunity and Transplantation, University College London, Royal Free Hospital, London NW3 2PF, United Kingdom;
  • Zech M; Institute of Immunity and Transplantation, University College London, Royal Free Hospital, London NW3 2PF, United Kingdom;
  • Xue SA; Institute of Immunity and Transplantation, University College London, Royal Free Hospital, London NW3 2PF, United Kingdom;
  • Uckert W; Institute of Biology, Humboldt University Berlin and Max Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.
  • Morris E; Institute of Immunity and Transplantation, University College London, Royal Free Hospital, London NW3 2PF, United Kingdom;
  • Chakraverty R; Transplantation Immunology Group, Department of Haematology, Division of Cancer Studies, University College London, London NW3 2PF, United Kingdom; and.
  • Stauss HJ; Institute of Immunity and Transplantation, University College London, Royal Free Hospital, London NW3 2PF, United Kingdom; h.stauss@ucl.ac.uk.
J Immunol ; 194(3): 1080-9, 2015 Feb 01.
Article en En | MEDLINE | ID: mdl-25539815
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Autoantígenos / Receptores de Antígenos de Linfocitos T / Linfocitos T CD4-Positivos / Linfocitos T CD8-positivos / Tolerancia Inmunológica / Antígenos de Neoplasias Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Autoantígenos / Receptores de Antígenos de Linfocitos T / Linfocitos T CD4-Positivos / Linfocitos T CD8-positivos / Tolerancia Inmunológica / Antígenos de Neoplasias Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Año: 2015 Tipo del documento: Article